BioCentury
ARTICLE | Financial News

Adamis raises $22.1 million, moves to NASDAQ

December 14, 2013 1:29 AM UTC

Adamis Pharmaceuticals Corp. (NASDAQ:ADMP) began trading on NASDAQ on Friday after raising $22.1 million through the sale of 3.7 million shares at $5.95 in a follow-on underwritten by CRT Capital and Newport Coast Securities. Adamis, which also implemented a 1-for-17 reverse stock split, proposed to raise up to $25 million in the offering last month. The company, which previously traded on the OTCQB, was down $1.87 (24%) to $5.95 on Friday. ...